RARA and hyperlipidemia: While the selective activation of RXR by bexarotene avoids toxicities associated with RAR activity, humans dosed with 1 often suffer hyperlipidemia and hypothyroidism [34], and sometimes cutaneous toxicity, as the most significant side effects.